Windtree Therapeutics, Inc.
WINT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $84 | $82 | $1,061 | $869 |
| Gross Profit | -$84 | -$82 | -$1,061 | -$869 |
| % Margin | – | – | – | – |
| R&D Expenses | $16,276 | $8,259 | $11,099 | $17,787 |
| G&A Expenses | $8,743 | $9 | $10,790 | $14,473 |
| SG&A Expenses | $8,743 | $9,198 | $10,790 | $14,473 |
| Sales & Mktg Exp. | $0 | $9,189 | $0 | $0 |
| Other Operating Expenses | -$84 | $0 | -$1,461 | -$869 |
| Operating Expenses | $24,935 | $17,457 | $20,428 | $31,391 |
| Operating Income | -$25,019 | -$17,539 | -$41,333 | -$77,280 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $23,226 | -$2,752 | $758 | -$45,363 |
| Pre-Tax Income | -$1,793 | -$20,291 | -$40,575 | -$77,623 |
| Tax Expense | $3,694 | $0 | -$1,367 | -$9,987 |
| Net Income | -$5,487 | -$20,291 | -$39,208 | -$67,636 |
| % Margin | – | – | – | – |
| EPS | -104.35 | -4,711.54 | -56,011 | -122,924 |
| % Growth | 97.8% | 91.6% | 54.4% | – |
| EPS Diluted | -104.35 | -4,711.54 | -56,011 | -122,924 |
| Weighted Avg Shares Out | 53 | 4 | 1 | 1 |
| Weighted Avg Shares Out Dil | 53 | 4 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $70 | $325 | $109 | $91 |
| Interest Expense | $235 | $50 | $53 | $114 |
| Depreciation & Amortization | $84 | $82 | $1,061 | $869 |
| EBITDA | -$1,474 | -$20,159 | -$39,461 | -$76,640 |
| % Margin | – | – | – | – |